CD40LG and COVID-19: The main strength of this study was the evaluation of immune cell profiling of the COVID-19 patients with and without IgM or IgG antibody production against SARS-CoV-2 nucleoprotein to demonstrate the possible role of lymphocyte subsets in humoral response.